Greenwich LifeSciences, Inc.

Ownership Transactions Reported by 6 Insiders

Symbol: GLSI on Nasdaq
Industry: Pharmaceutical Preparations
Location: 3992 Bluebonnet Dr, Building 14, Stafford, TX

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+272K	100%	$13.78	+$3.74M
Sells	0
Net	+2	+272K	100%		+$3.74M

Greenwich LifeSciences, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Snehal Patel	CEO and CFO, Director, 10%+ Owner	$76.3M	+$3.69M	+5.08%	Jan 6, 2025
Jaye Thompson	VP Clinical Reg Affairs	$3.41M	+$55.1K	+1.64%	Dec 24, 2024
David McWilliams	Director				Dec 24, 2024
Frank Daugherty	Chief Medical Officer, Director				Dec 24, 2024
Kenneth Hallock	Director				Dec 24, 2024
Eric Rothe	Director				Dec 24, 2024

Recent Insider Transactions by Companies or Individuals for Greenwich LifeSciences, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.